GlaxoSmithKline (GSK) Income Statement

5,232 Followers

GlaxoSmithKline Income Statement

Last quarter (Q1 2026), GlaxoSmithKline's total revenue was £7.63B, an increase of 1.50% from the same quarter last year. In Q1, GlaxoSmithKline's net income was £1.74B. See GlaxoSmithKline’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Total Revenue	£ 32.67B	£ 31.38B	£ 30.33B	£ 29.32B	£ 24.70B
Gross Profit	£ 23.65B	£ 22.33B	£ 21.76B	£ 19.77B	£ 16.53B
Operating Expenses	£ 15.31B	£ 18.31B	£ 15.02B	£ 13.34B	£ 12.18B
Depreciation and Amortization	£ 2.31B	£ 2.55B	£ 2.29B	£ 2.15B	£ 2.12B
EBITDA	£ 10.40B	£ 6.67B	£ 9.08B	£ 8.60B	£ 6.49B
Operating Income	£ 8.34B	£ 4.02B	£ 6.75B	£ 6.43B	£ 4.36B
Other Income/Expenses	£ -937.00M	£ -544.00M	£ -681.00M	£ -805.00M	£ -758.00M
Pretax Income	£ 7.40B	£ 3.48B	£ 6.06B	£ 5.63B	£ 3.60B
Net Income	£ 5.72B	£ 2.58B	£ 4.93B	£ 14.96B	£ 4.38B
Per Share Metrics
Basic EPS	£ 5.64	£ 1.26	£ 2.44	£ 2.44	£ 2.74
Diluted EPS	£ 5.56	£ 1.24	£ 2.40	£ 2.40	£ 2.70
Weighted Average Shares Outstanding	1.01B	2.04B	2.03B	2.01B	1.60B
Weighted Average Shares Outstanding (Diluted)	1.03B	2.07B	2.06B	2.04B	1.62B

Currency in GBP

GlaxoSmithKline (GSK) Income Statement

GlaxoSmithKline Income Statement

GlaxoSmithKline Earnings and Revenue History